<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04505774</url>
  </required_header>
  <id_info>
    <org_study_id>ACTIV-4 ACUTE</org_study_id>
    <secondary_id>1OT2HL156812-01</secondary_id>
    <nct_id>NCT04505774</nct_id>
    <nct_alias>NCT04359277</nct_alias>
  </id_info>
  <brief_title>Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE</brief_title>
  <acronym>ACTIV-4A</acronym>
  <official_title>A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic and Additional Strategies in Hospitalized Adults With COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Matthew Neal MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, open label, adaptive platform trial to compare the effectiveness of&#xD;
      antithrombotic and additional strategies for prevention of adverse outcomes in COVID-19&#xD;
      positive inpatients&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The severe acute respiratory syndrome coronavirus 2, which causes the highly contagious&#xD;
      coronavirus disease 2019 (COVID-19), has resulted in a global pandemic.&#xD;
&#xD;
      The clinical spectrum of COVID-19 infection is broad, encompassing asymptomatic infection,&#xD;
      mild upper respiratory tract illness, and severe viral pneumonia with respiratory failure and&#xD;
      death. The risk of thrombotic complications is increased, even as compared to other viral&#xD;
      respiratory illnesses, such as influenza. A pro-inflammatory cytokine response as well as&#xD;
      induction of procoagulant factors associated with COVID-19 has been proposed to contribute to&#xD;
      thrombosis as well as plaque rupture through local inflammation. Patients with COVID-19 are&#xD;
      at increased risk for arterial and vein thromboembolism, with high rates observed despite&#xD;
      thromboprophylaxis. Autopsy reports have noted micro and macro vascular thrombosis across&#xD;
      multiple organ beds consistent with an early hypercoagulable state.&#xD;
&#xD;
      Notably, in COVID-19, data in the U.K. and U.S. document that infection and outcomes of&#xD;
      infection are worse in African and Hispanic descent persons than in other groups. The reasons&#xD;
      for this are uncertain.&#xD;
&#xD;
      Viral Infection and Thrombosis A large body of literature links inflammation and coagulation;&#xD;
      altered hemostasis is a known complication of respiratory viral infections. Procoagulant&#xD;
      markers are severely elevated in viral infections. Specifically, proinflammatory cytokines in&#xD;
      viral infections upregulate expression of tissue factor, markers of thrombin generation,&#xD;
      platelet activation, and down-regulate natural anticoagulant proteins C and S.&#xD;
&#xD;
      Studies have demonstrated significant risk of deep venous thrombosis (DVT), pulmonary&#xD;
      embolism (PE), and myocardial infarction (MI) associated with viral respiratory infections.&#xD;
      In a series of patients with fatal influenza H1N1, 75% had pulmonary thrombi on autopsy (a&#xD;
      rate considerably higher than reported on autopsy studies among the general intensive care&#xD;
      unit population). Incidence ratio for acute myocardial infarction in the context of Influenza&#xD;
      A is over 10. Severe acute respiratory syndrome coronavirus-1 (SARS CoV-1) and influenza have&#xD;
      been associated with disseminated intravascular coagulation (DIC), endothelial damage, DVT,&#xD;
      PE, and large artery ischemic stroke. Patients with Influenza H1N1 and acute respiratory&#xD;
      distress syndrome (ARDS) had a 23.3-fold higher risk for pulmonary embolism, and a 17.9-fold&#xD;
      increased risk for deep vein thrombosis. Compared to those treated with systemic&#xD;
      anticoagulation, those without treatment were 33 times more likely to suffer a VTE.&#xD;
&#xD;
      Thrombosis, both microvascular and macrovascular, is a prominent feature in multiple organs&#xD;
      at autopsy in fatal cases of COVID-19. Thrombosis may thus contribute to respiratory failure,&#xD;
      renal failure, and hepatic injury in COVID-19. The number of megakaryocytes in tissues is&#xD;
      higher than in other forms of ARDS, and thrombi are platelet-rich based on specific staining.&#xD;
      Thrombotic stroke has been reported in young COVID-19 patients with no cardiovascular risk&#xD;
      factors. Both arterial and venous thrombotic events have been seen in increasing numbers of&#xD;
      hospitalized patients infected with COVID-19. The incidence of thrombosis has ranged from 10&#xD;
      to 30% in hospitalized patients; however, this varies by type of thrombosis captured&#xD;
      (arterial or vein) and severity of illness (ICU level care, requiring mechanical ventilation,&#xD;
      etc.).&#xD;
&#xD;
      Additional treatment strategies Data from the multiplatform randomized controlled trial&#xD;
      (mpRCT) demonstrated that (1) therapeutic dose anticoagulation with heparin was not&#xD;
      beneficial in improving clinical outcomes compared to standard of care prophylactic dose&#xD;
      heparin in severely ill (ICU level of care) patients, and (2) therapeutic dose&#xD;
      anticoagulation with heparin was beneficial in improving organ support free days compared to&#xD;
      standard of care prophylactic dose heparin in moderately ill (hospitalized and not requiring&#xD;
      organ support) patients. However, there remains significant residual risk for adverse&#xD;
      clinical outcomes and excess mortality for severely ill as well as moderately ill patients.&#xD;
&#xD;
      Antithrombotic regimens that are shown to be efficacious will be combined in clinical&#xD;
      practice with other agents to treat COVID-19 hospitalized patients. This adaptive platform&#xD;
      trial will test other promising agents when added to proven therapies, such as heparin. The&#xD;
      rationale and risks for each agent will be included in the arm-specific appendix. Two&#xD;
      specific agents to be added as arms, effective October 2021, include the P-selectin&#xD;
      inhibitor, Crizanlizumab as well as SGLT2 inhibitors. P-selectin may play a proximal role in&#xD;
      the inflammatory and thrombotic cascade in patients with COVID-19 and P-selectin inhibition&#xD;
      may be a effective in preventing downstream sequelae. In addition, SGLT-2 inhibitors have&#xD;
      been shown to decrease capillary leak and may promote vascular integrity in COVID-19.&#xD;
&#xD;
      This platform trial will have multiple arms, which may be dropped or added as the platform&#xD;
      trial progresses. Sample size will be flexible: the trial will be stopped for efficacy or&#xD;
      futility based on pre-determined statistical thresholds as defined in the arm-specific&#xD;
      appendices. Each arm will have an adaptive component for determinations of futility or&#xD;
      success.&#xD;
&#xD;
      Randomization assignments are at the participant level, stratified by enrolling site and by&#xD;
      ICU level of care vs non-ICU level of care and/or other arm-specific criteria.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 4, 2020</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">September 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>This is an adaptive design</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>There will be independent masked adjudicators.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>21 Day Organ Support (respiratory or vasopressor) Free Days</measure>
    <time_frame>21 days from study enrollment</time_frame>
    <description>which is defined as the number of days that a patient is alive and free of organ support through the first 21 days after trial entry. Organ Support is defined as receipt of non-invasive mechanical ventilation, high flow nasal canula oxygen, mechanical ventilation, or vasopressor therapy, with death at any time during the index hospitalization assigned -1 days.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary Endpoint all cause mortality</measure>
    <time_frame>28 days from study enrollment</time_frame>
    <description>Categorization of the primary endpoint into a three-level ordinal outcome (Death, invasive mechanical ventilation without death, neither invasive mechanical ventilation nor death)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other Platform Secondary Endpoints of Morbidity and Hospitalization</measure>
    <time_frame>28 days from study enrollment</time_frame>
    <description>Categorization of the primary endpoint into a three-level ordinal outcome (Death, organ support (any respiratory or cardiovascular) without death, neither organ support nor death) (for moderate illness severity at enrollment)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days free of death</measure>
    <time_frame>28 days from enrollment</time_frame>
    <description>Days free of death and respiratory and cardiovascular organ support and renal replacement therapy (RRT) during Index Hospitalization through Day 28.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death Composite</measure>
    <time_frame>28 days from enrollment</time_frame>
    <description>Composite endpoint of death, pulmonary embolism, systemic arterial thromboembolism, myocardial infarction, or ischemic stroke at hospital discharge or 28 days, whichever occurs first.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute kidney injury</measure>
    <time_frame>90 days from enrollment</time_frame>
    <description>Individual endpoints comprising the primary and secondary endpoint components; death during hospitalization, WHO clinical scale and 90 day mortality</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Primary Safety Endpoint of Major Bleeding</measure>
    <time_frame>28 days from study enrollment</time_frame>
    <description>Major bleeding (as defined by the ISTH)</description>
  </other_outcome>
  <other_outcome>
    <measure>Secondary Safety Endpoint of HIT</measure>
    <time_frame>28 days from study enrollment</time_frame>
    <description>Confirmed heparin induced thrombocytopenia (HIT)</description>
  </other_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Covid19</condition>
  <arm_group>
    <arm_group_label>Therapeutic Dose Anticoagulation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>increased dose of heparin above standard of care.&#xD;
1.0 - This arm was stopped in severe patients in December 2020 1.1 - this arm was stopped for moderate patients in June 2021</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Prophylactic Dose Anticoagulation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Heparin standard of care&#xD;
1.0 - this arm was stopped for all patients in January, 2021. 1.1 - this arm was reinstated for severe patients.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Therapeutic Dose Anticoagulation + P2Y12 inhibitor</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>increased dose of heparin above standard of care with an added P2Y12 inhibitor&#xD;
This Arm enrolled moderate illness patients only. Enrollment of moderate illness patients in the trial was ended per DSMB on June 19, 2021.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Prophylactic Dose Anticoagulation + P2Y12 inhibitor</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Heparin standard of care with an added P2Y12 inhibitor&#xD;
This Arm enrolled severe illness patients only.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care + Crizanlizumab</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Standard of care plus crizanlizumab infusion&#xD;
This arm will enroll moderate and severe illness patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care + SGLT2 inhibitor</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Standard of care plus SGLT2 inhibitor&#xD;
This arm will enroll moderate and severe illness patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>theraputic heparin</intervention_name>
    <description>increased dose of heparin above standard of care.</description>
    <arm_group_label>Therapeutic Dose Anticoagulation</arm_group_label>
    <arm_group_label>Therapeutic Dose Anticoagulation + P2Y12 inhibitor</arm_group_label>
    <other_name>unfractionated heparin</other_name>
    <other_name>Enoxaparin</other_name>
    <other_name>Dalteparin</other_name>
    <other_name>Tinzaparin</other_name>
    <other_name>Heparin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>prophylactic heparin</intervention_name>
    <description>standard of care dose of heparin</description>
    <arm_group_label>Prophylactic Dose Anticoagulation</arm_group_label>
    <arm_group_label>Prophylactic Dose Anticoagulation + P2Y12 inhibitor</arm_group_label>
    <other_name>enoxaparin</other_name>
    <other_name>dalteparin</other_name>
    <other_name>Tinzaparin</other_name>
    <other_name>Fondparinux</other_name>
    <other_name>Heparin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>P2Y12</intervention_name>
    <description>added P2Y12 inhibitor</description>
    <arm_group_label>Prophylactic Dose Anticoagulation + P2Y12 inhibitor</arm_group_label>
    <arm_group_label>Therapeutic Dose Anticoagulation + P2Y12 inhibitor</arm_group_label>
    <other_name>Ticagrelor</other_name>
    <other_name>Prasugrel</other_name>
    <other_name>Clopidogrel</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Crizanlizumab Injection</intervention_name>
    <description>crizanlizumab injection</description>
    <arm_group_label>Standard of Care + Crizanlizumab</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SGLT2 inhibitor</intervention_name>
    <description>sglt2 inhibitor</description>
    <arm_group_label>Standard of Care + SGLT2 inhibitor</arm_group_label>
    <other_name>dapagliflozin</other_name>
    <other_name>empagliflozin</other_name>
    <other_name>canagliflozin</other_name>
    <other_name>ertugliflozin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ≥ 18 years of age&#xD;
&#xD;
          -  Hospitalized for COVID-19&#xD;
&#xD;
          -  Enrolled within 72 hours of hospital admittance or 72 hours of positive COVID test&#xD;
&#xD;
          -  Expected to require hospitalization for &gt; 72 hours&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Imminent death&#xD;
&#xD;
          -  Requirement for chronic mechanical ventilation via tracheostomy prior to&#xD;
             hospitalization&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
        Inclusion Criteria for Arm E&#xD;
&#xD;
        Inclusion criteria contained in the master protocol in addition to the following:&#xD;
&#xD;
        Moderate illness severity - defined as non-ICU level of care at the time of randomization&#xD;
        (not receiving high flow nasal oxygen (HFNO), non-invasive ventilation (NIV), invasive&#xD;
        ventilation (IV), vasopressors or inotropes, or extracorporeal membrane oxygenation (ECMO)&#xD;
        OR Severe illness severity - defined as ICU level of care at the time of randomization&#xD;
        (receiving HFNO, NIV, IV, vasopressors or inotropes, or ECMO)&#xD;
&#xD;
        For moderate illness severity, participants are required to meet one or more of the&#xD;
        following risk criteria:&#xD;
&#xD;
          1. Age ≥ 65 years or&#xD;
&#xD;
          2. ≥2 of the following -&#xD;
&#xD;
               -  O2 supplementation &gt; 2 liters per minute&#xD;
&#xD;
               -  BMI ≥ 35&#xD;
&#xD;
               -  GFR ≤ 60&#xD;
&#xD;
               -  History of Type 2 diabetes&#xD;
&#xD;
               -  History of heart failure (regardless of ejection fraction)&#xD;
&#xD;
               -  D dimer ≥ 2x the site's upper limit of normal (ULN)&#xD;
&#xD;
               -  Troponin ≥ 2x the site's ULN&#xD;
&#xD;
               -  BNP≥100 pg/mL or NT-proBNP≥300 pg/mL&#xD;
&#xD;
               -  CRP ≥50 mg/L&#xD;
&#xD;
        Exclusion Criteria for Arm E&#xD;
&#xD;
          -  Exclusion criteria contained in the master protocol, and&#xD;
&#xD;
          -  Any condition that, in the opinion of the investigator, precludes the use of&#xD;
             crizanlizumab such as uncontrolled bleeding or severe anemia (hemoglobin&lt;4 g/dL)&#xD;
&#xD;
          -  Open label treatment with crizanlizumab within the past three months&#xD;
&#xD;
        Inclusion Criteria for Arm F&#xD;
&#xD;
        Inclusion criteria contained in the master protocol in addition to the following:&#xD;
&#xD;
        Moderate illness severity - defined as non-ICU level of care at the time of randomization&#xD;
        (not receiving high flow nasal oxygen (HFNO), non-invasive ventilation (NIV), invasive&#xD;
        ventilation (IV), vasopressors or inotropes, or extracorporeal membrane oxygenation (ECMO))&#xD;
        OR Severe illness severity - defined as ICU level of care at the time of randomization&#xD;
        (receiving HFNO, NIV, IV, vasopressors or inotropes, or ECMO)&#xD;
&#xD;
        For moderate illness severity, participants are required to meet one or more of the&#xD;
        following risk criteria:&#xD;
&#xD;
          1. Age ≥ 65 years or&#xD;
&#xD;
          2. ≥2 of the following-&#xD;
&#xD;
               -  O2 supplementation &gt; 2 liters per minute&#xD;
&#xD;
               -  BMI ≥ 35&#xD;
&#xD;
               -  GFR ≤ 60&#xD;
&#xD;
               -  History of Type 2 diabetes&#xD;
&#xD;
               -  History of heart failure (regardless of ejection fraction)&#xD;
&#xD;
               -  D dimer ≥ 2x the site's upper limit of normal (ULN)&#xD;
&#xD;
               -  Troponin ≥ 2x the site's ULN&#xD;
&#xD;
               -  BNP≥100 pg/mL or NT-proBNP≥300 pg/mL&#xD;
&#xD;
               -  CRP ≥50 mg/L&#xD;
&#xD;
        Exclusion Criteria for Arm F&#xD;
&#xD;
        In addition to the exclusion criteria noted in the master protocol, arm-specific exclusion&#xD;
        criteria are as follows:&#xD;
&#xD;
          -  Known hypersensitivity to any SGLT2 inhibitors&#xD;
&#xD;
          -  Type 1 diabetes&#xD;
&#xD;
          -  History of diabetic ketoacidosis&#xD;
&#xD;
          -  eGFR &lt;20 and/or requirement for renal replacement therapy&#xD;
&#xD;
          -  Open label treatment with any SGLT2 inhibitor&#xD;
&#xD;
               -  Based on a recommendation from the ACTIV4 DSMB on December 19, 2020, enrollment&#xD;
                  of patients requiring ICU level of care into the therapeutic anti-coagulation arm&#xD;
                  was stopped due to meeting a futility threshold and a potential for harm for this&#xD;
                  sub-group could not be excluded. Enrollment continues for moderately ill&#xD;
                  hospitalized COVID-19 patients.&#xD;
&#xD;
               -  Based on a recommendation from the ACTIV4 DSMB on June 18, 2021, enrollment of&#xD;
                  patients not requiring ICU level of care and randomized to P2Y12 or standard care&#xD;
                  was stopped due to meeting a futility threshold. Enrollment continues for&#xD;
                  severely ill (ICU level of care) hospitalized COVID-19 patients.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Judith Hochman, MD</last_name>
    <role>Study Chair</role>
    <affiliation>New York University - Grossman School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Scott Solomon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brigham and Women's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mikhail Kosiborod, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saint Lukes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jeffrey Berger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York University - Grossman School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Judith Hochman, MD</last_name>
    <phone>212-263-6927</phone>
    <email>Judith.Hochman@nyulangone.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Matthew Neal, MD</last_name>
    <phone>412-692-2850</phone>
    <email>nealm2@upmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shetal Gandotra</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Arizona</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85719</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bellal Joseph</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Arkansas for Medical Sciences</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Srikanth Vallurupalli</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Fontana</name>
      <address>
        <city>Fontana</city>
        <state>California</state>
        <zip>92335</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Conrad Liang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zahra Ajani</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Smidt Heart Institute at Cedars-Sinai</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oren Friedman</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ronald Reagan UCLA Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>George Lim</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>UC San Diego Hillcrest</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Todd Constantini</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zuckerberg San Francisco General Hospital</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucy Kornblith</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>UCSF San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Matthay</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zuckerberg San Francisco General Hospital</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94410</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucy Kornblith</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stanford University Medical Center</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Wilson</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90502</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janine Vintch</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Denver Health and Hospital Authority</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mitchell Cohen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Mary's Hospital &amp; Regional Medical Center</name>
      <address>
        <city>Grand Junction</city>
        <state>Colorado</state>
        <zip>81501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Logan McDaneld</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Francis Hospital and Medical Center</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sudhanshu Mulay</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32608</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie-Carmelle Elie</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memorial Hospital</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohannad Bisharat</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>AdventHealth Tampa</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33613</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Octavio Cosme</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Emory</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manila Gaddh</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Morehouse School of Medicine</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30310</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melvin Echols</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Queens Medical Center</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96813</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Guo</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memorial Hospital</name>
      <address>
        <city>Belleville</city>
        <state>Illinois</state>
        <zip>62226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Omar Almousalli</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cook County Health</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Saurabh Malhotra</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Illinois at Chicago Health (UIH)</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Quigley</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>OSF Little Company of Mary Medical Center (OSF LCM)</name>
      <address>
        <city>Evergreen Park</city>
        <state>Illinois</state>
        <zip>60805</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M. Bassel Atassi</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Indiana University Health Methodist Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Iowa</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rajat Kapoor</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kansas University Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lewis Satterwhite</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ochsner Clinic Foundation</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Effron</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Boston University</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Naomi Hamburg</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St Elizabeth's Medical Center</name>
      <address>
        <city>Brighton</city>
        <state>Massachusetts</state>
        <zip>02135</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Johnstone</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baystate Medical Center</name>
      <address>
        <city>Springfield</city>
        <state>Massachusetts</state>
        <zip>01199</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Tidswell</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Massachusetts</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alonso Alvaro</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Hyzy</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wayne State University</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Sherwin</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hennepin County Medical Center</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55415</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matt Prekker</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Mississippi Medical Center</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Kutcher</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine, ACCS Research</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Grant Bochicchio</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Medical Center of Southern Nevada</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chowdhury Ahsan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cooper Health</name>
      <address>
        <city>Camden</city>
        <state>New Jersey</state>
        <zip>08103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nitin Puri</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Englewood Health</name>
      <address>
        <city>Englewood</city>
        <state>New Jersey</state>
        <zip>07631</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashwin Jathavedam</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Atlantic Health System</name>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <zip>07960</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Whitman</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rutgers New Jersey Medical School</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yonatan Greenstein</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>AtlantiCare Regional Medical Center</name>
      <address>
        <city>Pomona</city>
        <state>New Jersey</state>
        <zip>08240</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anthony Macchiavelli</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Albany Medical College</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mandeep Sidhu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jacobi Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10461</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eleonora Gashi</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10461</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Gong</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mercy Hospital Buffalo</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14220</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raed Alnaji</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>VA New York Harbor Healthcare System</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Binita Shah</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>NYU Langone</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Berger, MD</last_name>
      <phone>212-263-0855</phone>
      <email>Jeffrey.Berger@nyulangone.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mt. Sinai Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lynne Richardson</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>SUNY Upstate University Hospital</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julius Gene Latorre</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Westchester Medical Center</name>
      <address>
        <city>Valhalla</city>
        <state>New York</state>
        <zip>10595</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Pan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Duke University Hospital</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27704</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lana Wahid</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wake Forest</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashish Khanna</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Akron General</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44307</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lokesh Venkatashaiah</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristin Hudock</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The MetroHealth System</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vidya Krishnan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abhijit Duggal</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ohio State Universtiy Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Exline</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mercy Health St Vincent Medical Center</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43608</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Salil Avasthi</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ascension St. John Clinical Research Institute</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicholas Hanna</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oregon Health and Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Akram Kahn</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Geisinger Research</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17822</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Parth Rao</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Doylestown Cardiology Associates</name>
      <address>
        <city>Doylestown</city>
        <state>Pennsylvania</state>
        <zip>18901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph McGarvey</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Penn State Health Milton S. Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven Moore</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Allyson Pishko</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Temple University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19141</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Bromberg</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>UPMC Presbyterian</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15260</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Huang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rhode Island Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ralph Rogers</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Miriam Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02906</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ralph Rogers</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sarah Cannon and HCA Research Institute</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Goodman</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Skyline Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Witt</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Texas at Austin</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hemali Patel</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ambarish Pandey</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical City Ft Worth</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ranjit Nair</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baylor Scott and White Medical Center - Temple</name>
      <address>
        <city>Temple</city>
        <state>Texas</state>
        <zip>76508</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Widmer</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>HCA Henrico Doctors Hospital</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amish Shah</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Swedish Hospital</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Wilson</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>West Virginia University CTR</name>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <zip>26506</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sunil Sharma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin Hospital; Meriter Hospital (UW affiliated)</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53715</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Sheehan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Sao Francisco de Assis</name>
      <address>
        <city>Braganca Paulista</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Murillo de Oliveira Antunes</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>União Brasileira de Educação e Assistência - Hospital São Lucas da PUCRS</name>
      <address>
        <city>Porto Alegre</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paulo Ricardo Avancini Caramori</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro de Estudos Clínicos do Hospital Cárdio Pulmonar</name>
      <address>
        <city>Salvador</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luiz Eduardo Fonteles Ritt</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fundação Faculdade Regional De Medicina De São José Do Rio Preto</name>
      <address>
        <city>São José do Rio Preto</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lilia Nigro Maia</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Instituto Dante Pazzanese de Cardiologia</name>
      <address>
        <city>São Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Idelzuita Leandro Liporace</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da USP-InCor-HCFMUSP</name>
      <address>
        <city>São Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexandre de Matos Soeiro</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero Sant Anna e San Sebastiano</name>
      <address>
        <city>Caserta</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paolo Maggi</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Maria Cecilia Hospital , Cotignola, Ravenna</name>
      <address>
        <city>Cotignola</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lorenzo Filippo Mantovani</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Università degli Studi di Ferrara, Ferrara</name>
      <address>
        <city>Ferrara</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marco Contoli</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero -Universitaria Careggi</name>
      <address>
        <city>Firenze</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessandro Bartoloni</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Policlinico di Napoli, Napoli</name>
      <address>
        <city>Napoli</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicola Coppola</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>AOU Policlinico di Palermo, Palermo</name>
      <address>
        <city>Palermo</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Cascio</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>ASL-1 Imperiese, Sanremo</name>
      <address>
        <city>Sanremo</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giovanni Cenderello</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario A Coruna</name>
      <address>
        <city>A Coruna</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jesus Peteiro</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen del Mar</name>
      <address>
        <city>Almeria</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Luis Blanco Coronado</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Arnau de Vilanova</name>
      <address>
        <city>Lleida</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fernando Worner</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Esteban Lopez-de-Sa</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Ramon Y Cajal</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Lopez-Sendon Moreno</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Ramon Y Cajal</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Luis Lopez-Sendon Moreno</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario de Salamanca</name>
      <address>
        <city>Salamanca</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miguel Marcos Martin</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario de Santiago de Compostela</name>
      <address>
        <city>Santiago de Compostela</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Ramon Gonzalez Juanatey</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
    <country>Italy</country>
    <country>Spain</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, Nigoghossian C, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Giri J, Cushman M, Quéré I, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Caprini JA, Tafur AJ, Burton JR, Francese DP, Wang EY, Falanga A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Steg PG, Stone GW, Rosenkranz S, Goldhaber SZ, Parikh SA, Monreal M, Krumholz HM, Konstantinides SV, Weitz JI, Lip GYH; Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031. Epub 2020 Apr 17. Review.</citation>
    <PMID>32311448</PMID>
  </reference>
  <reference>
    <citation>Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV, Endeman H. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.</citation>
    <PMID>32291094</PMID>
  </reference>
  <reference>
    <citation>Middeldorp S, Coppens M, van Haaps TF, Foppen M, Vlaar AP, Müller MCA, Bouman CCS, Beenen LFM, Kootte RS, Heijmans J, Smits LP, Bonta PI, van Es N. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020 Aug;18(8):1995-2002. doi: 10.1111/jth.14888. Epub 2020 Jul 27.</citation>
    <PMID>32369666</PMID>
  </reference>
  <reference>
    <citation>Poissy J, Goutay J, Caplan M, Parmentier E, Duburcq T, Lassalle F, Jeanpierre E, Rauch A, Labreuche J, Susen S; Lille ICU Haemostasis COVID-19 Group. Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence. Circulation. 2020 Jul 14;142(2):184-186. doi: 10.1161/CIRCULATIONAHA.120.047430. Epub 2020 Apr 24.</citation>
    <PMID>32330083</PMID>
  </reference>
  <reference>
    <citation>Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.</citation>
    <PMID>32171076</PMID>
  </reference>
  <reference>
    <citation>Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.</citation>
    <PMID>32220112</PMID>
  </reference>
  <reference>
    <citation>Xu J, W.L., Zhao L, et al. , Risk assessment of venous thromboembolism and bleeding in COVID-19 patients. BMC Pulmonary Medicine 2020.</citation>
  </reference>
  <reference>
    <citation>Danzi GB, Loffi M, Galeazzi G, Gherbesi E. Acute pulmonary embolism and COVID-19 pneumonia: a random association? Eur Heart J. 2020 May 14;41(19):1858. doi: 10.1093/eurheartj/ehaa254.</citation>
    <PMID>32227120</PMID>
  </reference>
  <reference>
    <citation>Xie Y, Wang X, Yang P, Zhang S. COVID-19 Complicated by Acute Pulmonary Embolism. Radiol Cardiothorac Imaging. 2020 Mar 16;2(2):e200067. doi: 10.1148/ryct.2020200067. eCollection 2020 Apr.</citation>
    <PMID>33778561</PMID>
  </reference>
  <reference>
    <citation>Beristain-Covarrubias N, Perez-Toledo M, Thomas MR, Henderson IR, Watson SP, Cunningham AF. Understanding Infection-Induced Thrombosis: Lessons Learned From Animal Models. Front Immunol. 2019 Nov 5;10:2569. doi: 10.3389/fimmu.2019.02569. eCollection 2019. Review.</citation>
    <PMID>31749809</PMID>
  </reference>
  <reference>
    <citation>Clayton TC, Gaskin M, Meade TW. Recent respiratory infection and risk of venous thromboembolism: case-control study through a general practice database. Int J Epidemiol. 2011 Jun;40(3):819-27. doi: 10.1093/ije/dyr012. Epub 2011 Feb 15.</citation>
    <PMID>21324940</PMID>
  </reference>
  <reference>
    <citation>Goeijenbier M, van Wissen M, van de Weg C, Jong E, Gerdes VE, Meijers JC, Brandjes DP, van Gorp EC. Review: Viral infections and mechanisms of thrombosis and bleeding. J Med Virol. 2012 Oct;84(10):1680-96. doi: 10.1002/jmv.23354. Review.</citation>
    <PMID>22930518</PMID>
  </reference>
  <reference>
    <citation>Smeeth L, Cook C, Thomas S, Hall AJ, Hubbard R, Vallance P. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet. 2006 Apr 1;367(9516):1075-1079. doi: 10.1016/S0140-6736(06)68474-2.</citation>
    <PMID>16581406</PMID>
  </reference>
  <reference>
    <citation>Harms PW, Schmidt LA, Smith LB, Newton DW, Pletneva MA, Walters LL, Tomlins SA, Fisher-Hubbard A, Napolitano LM, Park PK, Blaivas M, Fantone J, Myers JL, Jentzen JM. Autopsy findings in eight patients with fatal H1N1 influenza. Am J Clin Pathol. 2010 Jul;134(1):27-35. doi: 10.1309/AJCP35KOZSAVNQZW.</citation>
    <PMID>20551263</PMID>
  </reference>
  <reference>
    <citation>Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, Karnauchow T, Katz K, Ko DT, McGeer AJ, McNally D, Richardson DC, Rosella LC, Simor A, Smieja M, Zahariadis G, Gubbay JB. Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection. N Engl J Med. 2018 Jan 25;378(4):345-353. doi: 10.1056/NEJMoa1702090.</citation>
    <PMID>29365305</PMID>
  </reference>
  <reference>
    <citation>Wong RS, Wu A, To KF, Lee N, Lam CW, Wong CK, Chan PK, Ng MH, Yu LM, Hui DS, Tam JS, Cheng G, Sung JJ. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ. 2003 Jun 21;326(7403):1358-62.</citation>
    <PMID>12816821</PMID>
  </reference>
  <reference>
    <citation>Obi AT, Tignanelli CJ, Jacobs BN, Arya S, Park PK, Wakefield TW, Henke PK, Napolitano LM. Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients. J Vasc Surg Venous Lymphat Disord. 2019 May;7(3):317-324. doi: 10.1016/j.jvsv.2018.08.010. Epub 2018 Nov 23. Erratum in: J Vasc Surg Venous Lymphat Disord. 2019 Jul;7(4):621.</citation>
    <PMID>30477976</PMID>
  </reference>
  <reference>
    <citation>Rapkiewicz AV, Mai X, Carsons SE, Pittaluga S, Kleiner DE, Berger JS, Thomas S, Adler NM, Charytan DM, Gasmi B, Hochman JS, Reynolds HR. Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series. EClinicalMedicine. 2020 Jun 25;24:100434. doi: 10.1016/j.eclinm.2020.100434. eCollection 2020 Jul.</citation>
    <PMID>32766543</PMID>
  </reference>
  <reference>
    <citation>Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP, De Leacy RA, Shigematsu T, Ladner TR, Yaeger KA, Skliut M, Weinberger J, Dangayach NS, Bederson JB, Tuhrim S, Fifi JT. Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young. N Engl J Med. 2020 May 14;382(20):e60. doi: 10.1056/NEJMc2009787. Epub 2020 Apr 28.</citation>
    <PMID>32343504</PMID>
  </reference>
  <reference>
    <citation>Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JCT, Fogerty AE, Waheed A, Goodarzi K, Bendapudi PK, Bornikova L, Gupta S, Leaf DE, Kuter DJ, Rosovsky RP. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020 Jul 23;136(4):489-500. doi: 10.1182/blood.2020006520.</citation>
    <PMID>32492712</PMID>
  </reference>
  <reference>
    <citation>Centers for Disease Control and Prevention. COVID-19 in Racial and Ethnic Minority Groups. 2020.</citation>
  </reference>
  <reference>
    <citation>Price-Haywood EG, Burton J, Fort D, Seoane L. Hospitalization and Mortality among Black Patients and White Patients with Covid-19. N Engl J Med. 2020 Jun 25;382(26):2534-2543. doi: 10.1056/NEJMsa2011686. Epub 2020 May 27.</citation>
    <PMID>32459916</PMID>
  </reference>
  <reference>
    <citation>Aldridge RW, Lewer D, Katikireddi SV, Mathur R, Pathak N, Burns R, Fragaszy EB, Johnson AM, Devakumar D, Abubakar I, Hayward A. Black, Asian and Minority Ethnic groups in England are at increased risk of death from COVID-19: indirect standardisation of NHS mortality data. Version 2. Wellcome Open Res. 2020 Jun 24 [revised 2020 Jan 1];5:88. doi: 10.12688/wellcomeopenres.15922.2. eCollection 2020.</citation>
    <PMID>32613083</PMID>
  </reference>
  <reference>
    <citation>Niedzwiedz CL, O'Donnell CA, Jani BD, Demou E, Ho FK, Celis-Morales C, Nicholl BI, Mair FS, Welsh P, Sattar N, Pell JP, Katikireddi SV. Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank. BMC Med. 2020 May 29;18(1):160. doi: 10.1186/s12916-020-01640-8.</citation>
    <PMID>32466757</PMID>
  </reference>
  <reference>
    <citation>Millett GA, Jones AT, Benkeser D, Baral S, Mercer L, Beyrer C, Honermann B, Lankiewicz E, Mena L, Crowley JS, Sherwood J, Sullivan PS. Assessing differential impacts of COVID-19 on black communities. Ann Epidemiol. 2020 Jul;47:37-44. doi: 10.1016/j.annepidem.2020.05.003. Epub 2020 May 14.</citation>
    <PMID>32419766</PMID>
  </reference>
  <reference>
    <citation>Kamin-Mukaz D, Gergi M, Koh I, Zakai NA, Judd SE, Sholzberg M, Bauman Kreuziger L, Freeman K, Colovos C, Cushman M. Biomarkers of COVID-19 coagulopathy and D-dimer in a biracial cohort study [abstract]. Res Pract Thromb Haemost 2020;4:Suppl2.</citation>
  </reference>
  <reference>
    <citation>Kosiborod MN, Esterline R, Furtado RHM, Oscarsson J, Gasparyan SB, Koch GG, Martinez F, Mukhtar O, Verma S, Chopra V, Buenconsejo J, Langkilde AM, Ambery P, Tang F, Gosch K, Windsor SL, Akin EE, Soares RVP, Moia DDF, Aboudara M, Hoffmann Filho CR, Feitosa ADM, Fonseca A, Garla V, Gordon RA, Javaheri A, Jaeger CP, Leaes PE, Nassif M, Pursley M, Silveira FS, Barroso WKS, Lazcano Soto JR, Nigro Maia L, Berwanger O. Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Diabetes Endocrinol. 2021 Sep;9(9):586-594. doi: 10.1016/S2213-8587(21)00180-7. Epub 2021 Jul 21.</citation>
    <PMID>34302745</PMID>
  </reference>
  <reference>
    <citation>Leucker TM, Osburn WO, Reventum P, Smith K, Claggett B, Kirwan BA, de Brouwer S, Williams MS, Gerstenblith G, Hager DN, Streiff MB, Solomon SD, Lowenstein CJ. Effect of crizanlizumab, a P-selectin inhibitor, in COVID-19: A randomized controlled trial. JACC Basic Trans Sci. In Press</citation>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>August 6, 2020</study_first_submitted>
  <study_first_submitted_qc>August 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 10, 2020</study_first_posted>
  <last_update_submitted>October 27, 2021</last_update_submitted>
  <last_update_submitted_qc>October 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Matthew Neal MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>anti-coagulation</keyword>
  <keyword>antithrombosis</keyword>
  <keyword>anticoagulation</keyword>
  <keyword>ACTIV</keyword>
  <keyword>inpatient</keyword>
  <keyword>heparin</keyword>
  <keyword>p2y12</keyword>
  <keyword>endothelial dysfunction</keyword>
  <keyword>vascular integrity</keyword>
  <keyword>P-selectin</keyword>
  <keyword>crizanlizumab</keyword>
  <keyword>SGLT-2 inhibitor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dapagliflozin</mesh_term>
    <mesh_term>Empagliflozin</mesh_term>
    <mesh_term>Canagliflozin</mesh_term>
    <mesh_term>Ertugliflozin</mesh_term>
    <mesh_term>Sodium-Glucose Transporter 2 Inhibitors</mesh_term>
    <mesh_term>Heparin</mesh_term>
    <mesh_term>Calcium heparin</mesh_term>
    <mesh_term>Enoxaparin</mesh_term>
    <mesh_term>Dalteparin</mesh_term>
    <mesh_term>Tinzaparin</mesh_term>
    <mesh_term>Heparin, Low-Molecular-Weight</mesh_term>
    <mesh_term>Enoxaparin sodium</mesh_term>
    <mesh_term>Clopidogrel</mesh_term>
    <mesh_term>Ticagrelor</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data will be shared as per NIH guidelines.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

